相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals
Maria Sanchez-Azofra et al.
LIVER INTERNATIONAL (2021)
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study
Gamal Shiha et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
Qiushi Chen et al.
JAMA NETWORK OPEN (2020)
For Whom is Hepatocellular Carcinoma Surveillance After Sustained Virologic Response Cost-Effective?
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat et al.
LANCET (2019)
Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis
Debra T. Choi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis
Hooman Farhang Zangneh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada
Mel Krajden et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2019)
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue
Changqing Zhao et al.
LIVER INTERNATIONAL (2018)
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon et al.
GASTROENTEROLOGY (2018)
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso et al.
GASTROENTEROLOGY (2018)
The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study
Darrick K. Li et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Screening for Cervical Cancer in Primary Care A Decision Analysis for the US Preventive Services Task Force
Jane J. Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based study
Mohamed Abd El-Fattah et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?
Raoel Maan et al.
GASTROENTEROLOGY (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials
Sorin Ursoniu et al.
NUTRITION REVIEWS (2017)
Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
Nicolas Goossens et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals
Jagpreet Chhatwal et al.
HEPATOLOGY (2016)
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task Force
Amy B. Knudsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment
Wei Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors
Iswanto Sucandy et al.
HPB (2016)
Screening for Hepatocellular Carcinoma in Chronic Liver Disease
Diana Chirovsky et al.
ANNALS OF INTERNAL MEDICINE (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Screening for Hepatocellular Carcinoma in Chronic Liver Disease A Systematic Review
Devan Kansagara et al.
ANNALS OF INTERNAL MEDICINE (2014)
Hepatocellular carcinoma: Diagnostic criteria by imaging techniques
Maxime Ronot et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Hepatocellular Carcinoma Screening in Patients With Compensated Hepatitis C Virus (HCV)-Related Cirrhosis Aware of Their HCV Status Improves Survival: A Modeling Approach
Abbas Mourad et al.
HEPATOLOGY (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Amit G. Singal et al.
PLOS MEDICINE (2014)
Improving Hepatocellular Carcinoma Screening: Applying Lessons From Colorectal Cancer Screening
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States
Jagpreet Chhatwal et al.
VALUE IN HEALTH (2013)
Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years A Comparative Modeling Study of Risk
Nicolien T. van Ravesteyn et al.
ANNALS OF INTERNAL MEDICINE (2012)
Whither hepatocellular carcinoma screening?
Morris Sherman
HEPATOLOGY (2012)
Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment
Adriana Toro et al.
SURGICAL ONCOLOGY-OXFORD (2012)
Trends in Organ Donation and Transplantation in the United States, 1999-2008
R. A. Wolfe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Race, Ethnicity, and Socioeconomic Status Influence the Survival of Patients With Hepatocellular Carcinoma in the United States
Avo Artinyan et al.
CANCER (2010)
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
Ana-Carolina Cardoso et al.
JOURNAL OF HEPATOLOGY (2010)
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
A. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The burden of illness associated with hepatocellular carcinoma in the United States
Kathleen Lang et al.
JOURNAL OF HEPATOLOGY (2009)
Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D Utility Index
Yin-Bun Cheung et al.
VALUE IN HEALTH (2009)
Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis
J. Thompson Coon et al.
BRITISH JOURNAL OF CANCER (2008)
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
Karin L. Andersson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
Tito Livraghi et al.
HEPATOLOGY (2008)
Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores
Janel Hanmer et al.
MEDICAL DECISION MAKING (2006)
Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation
R Lencioni et al.
RADIOLOGY (2005)
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey
I Ikai et al.
CANCER (2004)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Assessing health-related quality of life pre- and post-liver transplantation: A prospective multicenter study
J Ratcliffe et al.
LIVER TRANSPLANTATION (2002)
分享论文
